IL96654A - Sutral derivatives containing hydroxybenzyl and sulfur-converted, and pharmaceutical preparations containing them - Google Patents
Sutral derivatives containing hydroxybenzyl and sulfur-converted, and pharmaceutical preparations containing themInfo
- Publication number
- IL96654A IL96654A IL9665490A IL9665490A IL96654A IL 96654 A IL96654 A IL 96654A IL 9665490 A IL9665490 A IL 9665490A IL 9665490 A IL9665490 A IL 9665490A IL 96654 A IL96654 A IL 96654A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- alkyl
- formula
- hydrogen
- inclusive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Eye Examination Apparatus (AREA)
- Surgical Instruments (AREA)
- Nonmetallic Welding Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10896290A IL108962A (en) | 1989-12-21 | 1990-12-13 | Use of hydrocarbon-containing sulfur-containing heterocyclic histories, process for their preparation and pharmaceutical preparations containing them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45420389A | 1989-12-21 | 1989-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL96654A true IL96654A (en) | 1995-06-29 |
Family
ID=23803709
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10896290A IL108962A (en) | 1989-12-21 | 1990-12-13 | Use of hydrocarbon-containing sulfur-containing heterocyclic histories, process for their preparation and pharmaceutical preparations containing them |
IL9665490A IL96654A (en) | 1989-12-21 | 1990-12-13 | Sutral derivatives containing hydroxybenzyl and sulfur-converted, and pharmaceutical preparations containing them |
IL10896294A IL108962A0 (en) | 1989-12-21 | 1994-03-14 | Use of hydroxybenzyl substituted sulfur containing heterocyclic derivatives, a process for their preparation and pharmaceutical compositions containing them |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10896290A IL108962A (en) | 1989-12-21 | 1990-12-13 | Use of hydrocarbon-containing sulfur-containing heterocyclic histories, process for their preparation and pharmaceutical preparations containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10896294A IL108962A0 (en) | 1989-12-21 | 1994-03-14 | Use of hydroxybenzyl substituted sulfur containing heterocyclic derivatives, a process for their preparation and pharmaceutical compositions containing them |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0434394B1 (de) |
JP (1) | JP3036853B2 (de) |
KR (1) | KR0176243B1 (de) |
CN (1) | CN1029846C (de) |
AT (1) | ATE169294T1 (de) |
AU (1) | AU639734B2 (de) |
CA (1) | CA2032330C (de) |
CY (1) | CY2100B1 (de) |
DE (1) | DE69032537T2 (de) |
DK (1) | DK0434394T3 (de) |
ES (1) | ES2121748T3 (de) |
FI (2) | FI104251B (de) |
HU (1) | HU216732B (de) |
IE (1) | IE904633A1 (de) |
IL (3) | IL108962A (de) |
MX (1) | MX23803A (de) |
NO (1) | NO300458B1 (de) |
NZ (1) | NZ236472A (de) |
PT (1) | PT96198B (de) |
RU (2) | RU2036915C1 (de) |
YU (1) | YU240690A (de) |
ZA (1) | ZA9010041B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU87339A1 (fr) * | 1988-09-20 | 1990-04-06 | Oreal | Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant |
US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
CZ181493A3 (en) * | 1992-09-10 | 1994-03-16 | Lilly Co Eli | The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease |
ATE135697T1 (de) * | 1992-10-28 | 1996-04-15 | Shionogi & Co | Benzylidenderivate |
US6251928B1 (en) | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
US5563277A (en) * | 1994-12-21 | 1996-10-08 | Eli Lilly And Company | Process for preparing benzyl-substituted rhodanine derivatives |
DE69608512T2 (de) * | 1995-09-07 | 2001-01-25 | Eli Lilly And Co., Indianapolis | Verfahren zur Herstellung von benzylsubstituierten Rhodaninederivaten |
PT761656E (pt) * | 1995-09-07 | 2001-04-30 | Lilly Co Eli | Forma cristalina de tazofelona((+,-)-5-((3,5-bis(1,1-dimetiletil)-4-hidroxifenil)metil)-4-tiazolidinona) |
EP0779282A1 (de) * | 1995-12-14 | 1997-06-18 | Eli Lilly And Company | Thiomorpholinon-Verbindungen zur Behandlung von Multiple-Sklerose |
US5981523A (en) * | 1996-02-05 | 1999-11-09 | Eli Lilly And Company | Compounds and methods for treating multiple sclerosis |
US6005142A (en) | 1996-09-03 | 1999-12-21 | Eli Lilly And Company | Process for preparing benzyl-substituted rhodanine derivatives |
US6063799A (en) * | 1996-09-03 | 2000-05-16 | Eli Lilly And Company | Alternate crystal form of Tazofelone |
AU6330999A (en) * | 1998-09-30 | 2000-04-17 | Roche Diagnostics Gmbh | Rhodanine derivatives for the treatment and prevention of metabolic bone disorders |
WO2000018747A1 (en) * | 1998-09-30 | 2000-04-06 | Roche Diagnostics Gmbh | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
WO2000018746A1 (en) * | 1998-09-30 | 2000-04-06 | Roche Diagnostics Gmbh | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders |
PL376147A1 (en) * | 2002-09-30 | 2005-12-27 | The Regents Of The University Of California | Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
US7235573B2 (en) | 2002-09-30 | 2007-06-26 | The Regents Of The University Of California | Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
AU2002953533A0 (en) | 2002-12-24 | 2003-01-16 | Arthron Limited | Fc receptor modulating compounds and compositions |
EA022721B1 (ru) * | 2010-04-15 | 2016-02-29 | Мерк Патент Гмбх | Способ получения гидрохинонов |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL79648A (en) * | 1985-08-09 | 1991-12-12 | Lilly Co Eli | Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation |
IE940525L (en) * | 1988-05-25 | 1989-11-25 | Warner Lambert Co | Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents |
CA2013599C (en) * | 1989-04-07 | 1999-11-16 | Jill A. Panetta | Aryl-substituted rhodanine derivatives |
-
1990
- 1990-12-13 IL IL10896290A patent/IL108962A/en not_active IP Right Cessation
- 1990-12-13 IL IL9665490A patent/IL96654A/en not_active IP Right Cessation
- 1990-12-13 ZA ZA9010041A patent/ZA9010041B/xx unknown
- 1990-12-14 PT PT96198A patent/PT96198B/pt active IP Right Grant
- 1990-12-14 NZ NZ236472A patent/NZ236472A/xx unknown
- 1990-12-14 CA CA002032330A patent/CA2032330C/en not_active Expired - Fee Related
- 1990-12-19 EP EP90313923A patent/EP0434394B1/de not_active Expired - Lifetime
- 1990-12-19 AT AT90313923T patent/ATE169294T1/de not_active IP Right Cessation
- 1990-12-19 DK DK90313923T patent/DK0434394T3/da active
- 1990-12-19 DE DE69032537T patent/DE69032537T2/de not_active Expired - Fee Related
- 1990-12-19 NO NO905478A patent/NO300458B1/no not_active IP Right Cessation
- 1990-12-19 AU AU68266/90A patent/AU639734B2/en not_active Ceased
- 1990-12-19 MX MX2380390A patent/MX23803A/es unknown
- 1990-12-19 ES ES90313923T patent/ES2121748T3/es not_active Expired - Lifetime
- 1990-12-19 FI FI906273A patent/FI104251B/fi not_active IP Right Cessation
- 1990-12-19 KR KR1019900021001A patent/KR0176243B1/ko not_active IP Right Cessation
- 1990-12-20 HU HU908368A patent/HU216732B/hu not_active IP Right Cessation
- 1990-12-20 CN CN90109846A patent/CN1029846C/zh not_active Expired - Fee Related
- 1990-12-20 RU SU904894177A patent/RU2036915C1/ru active
- 1990-12-20 JP JP2413313A patent/JP3036853B2/ja not_active Expired - Fee Related
- 1990-12-20 IE IE463390A patent/IE904633A1/en not_active Application Discontinuation
- 1990-12-20 YU YU240690A patent/YU240690A/sh unknown
-
1991
- 1991-12-24 RU SU915010352A patent/RU2050355C1/ru active
-
1994
- 1994-03-14 IL IL10896294A patent/IL108962A0/xx unknown
-
1998
- 1998-09-07 CY CY9800024A patent/CY2100B1/xx unknown
-
1999
- 1999-08-10 FI FI991698A patent/FI19991698A/fi unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0434394B1 (de) | Verbindungen zur Behandlung von Bauchentzündungen | |
US5387690A (en) | Method of treating inflammatory bowel disease | |
CA1304371C (en) | Benzoxazole derivatives and preparation thereof | |
KR20030097596A (ko) | 치환된 티아졸리딘디온 유도체 | |
KR20000016412A (ko) | 신규한 치환 2,4-티아졸리디네디온 유도체, 이의제조 방법 및이를 함유하는 약제학적 조성물 | |
AU629322B2 (en) | Aryl-substituted rhodanine derivatives | |
US5158966A (en) | Method of treating type i diabetes | |
KR960012206B1 (ko) | 티아졸리딘-2,4-디온 유도체 및 이의 염, 이의 제조방법 및 이의 용도 | |
EP0283036B1 (de) | Benzoxazin-Derivate und Verfahren zu ihrer Herstellung | |
US5731336A (en) | Method for treating multiple sclerosis | |
CH633010A5 (fr) | Derives de l'isoquinoleine, leur preparation et medicament qui les contient. | |
US4845231A (en) | Tetrazoles and their use as hypoglycemic agents | |
US5563277A (en) | Process for preparing benzyl-substituted rhodanine derivatives | |
US5691367A (en) | Aryl-substituted rhodanine derivatives | |
JPH0469385A (ja) | 新規イミダゾリン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |